Company Filing History:
1 out of 5 
1 out of 2,008 
1 out of 41 
Years Active: 2014
Title: Zeljko Vusjaskovic: Innovator in Cancer Therapy
Introduction
Zeljko Vusjaskovic is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of cancer therapy, particularly through his innovative methods involving low molecular weight antioxidants. His work aims to enhance the prevention and treatment of cancer, showcasing his dedication to improving healthcare outcomes.
Latest Patents
Zeljko Vusjaskovic holds 1 patent related to cancer therapy. This patent focuses on a method of preventing or treating cancer using low molecular weight antioxidants, such as mimetics of superoxide dismutase (SOD). The invention also encompasses compounds and compositions that are suitable for use in these therapeutic methods.
Career Highlights
Throughout his career, Zeljko has worked with prominent organizations, including Aeolus Sciences, Inc. and Duke University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Zeljko has collaborated with esteemed colleagues, including James D. Crapo and Brian J. Day. These partnerships have further enriched his research and development efforts in cancer therapy.
Conclusion
Zeljko Vusjaskovic is a dedicated inventor whose work in cancer therapy has the potential to make a significant impact on the treatment of this challenging disease. His innovative approach and collaborations highlight the importance of research in advancing medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.